Clint Eastwood, who took Hollywood by storm in the 1960s as the “Man with No Name" in Sergio Leone's “Dollars Trilogy” is actually quite protective of his name. He is collecting another fistful of dollars in a second successful lawsuit - this time against Norok Innovations, a California-based Internet marketing company.
What Happened: The verdict awarded Eastwood and Garrapata, the company that owns the rights to the actor's likeness, a cool $2 million for using Eastwood’s fame to drive online traffic via a “hidden metatag game” to a website selling CBD products, per The Hollywood Reporter. Fake news articles and manipulated search results made it appear as if Eastwood was endorsing CBD products.
Apparently, Eastwood took issue with the way Norok lured online shoppers to its website.
“We are pleased with the Court’s decision as it recognizes the substantial harm that false endorsements cause,” said Eastwood’s attorney Jordan Susman. “It further sends a message to such offenders that they cannot evade liability by ignoring the legal system. This is a judgment we look forward to collecting.”
Eastwood also wants the world to know he does not care for cannabis or CBD any more than he does fake endorsements and online scams.
At 92, the actor, director and producer has been in numerous legal battles over the years to protect his name, image and reputation. Of late, many have been against CBD manufacturers and marketers in an effort to clarify that he's not now and has never been involved in the cannabis industry.
In October 2021 Eastwood was awarded $6.1 million in damages and legal fees against Mediatonas UAB in a similar lawsuit against the Lithuanian company, which also published fake interviews giving the impression that the movie star endorsed its CBD.
“In truth, Mr. Eastwood has no connection of any kind whatsoever to any CBD products and never gave such an interview,” said the lawsuit against Mediatonas, which was filed in Los Angeles federal court in July 2020.
Photo: Courtesy of Siebbi on Flickr
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.